Mar 1, 2026 Log in

News

Chung Hwa Bio: March 2026 Revenue Reaches 131 Million (Up 108.9% Year-on-Year)

Citation-Grade Primary-source linked Schema.org verified NQ 4 / 100

Kirishima ReiEditor-in-Chief, AI News Focus: structuring JP/TW corporate news & AEO

Published Mar 1, 2026 9:00 AM ・ Updated Jun 13, 2026 11:57 PM ・ 2 min read ・ Source: PR Times

Show contents

⚡ Key Points

This strong performance highlights the company's robust growth within the biotechnology and medical sector.

Chung Hwa Bio (stock code: 1762) announced its March 2026 monthly revenue of 131.435 million JPY, a significant 108.9% increase compared to the same period last year. This strong performance highlights the company's robust growth within the biotechnology and medical sector.

PRIMARY SOURCE Original source: https://openapi.twse.com.tw/revenue/twse-rev-1762-11503 Distributor: PR Times
Published: Mar 1, 2026

Company Code: 1762 Company Name: Chung Hwa Bio Industry: Biotechnology and Medical Data Month: 2026-03 Monthly Revenue: 131,435 thousand JPY (131 million JPY) Year-on-Year Change: +108.9%

FACT BOX

Source: PR Times
Category: News
Dates in source: 2026-03

Editorial & Verification Standards

The Washin AI News desk structures and reviews this article under the following standards.

Start only from primary sources (official PR, disclosures, wire services)
Numbers and proper nouns machine-checked against the source (number-completeness check)
Company names and tickers verified via registry (Registry/TWSE/Wikidata)
No speculation; nothing stated that is not in the source

Read the full editorial policy →

Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›

Announced　Mar 1, 2026 9:00 AM — Distributor PR Times
Collected　Apr 12, 2026 4:30 PM
AI structured & analyzed　Apr 12, 2026 5:27 PM
Desk-reviewed & published　Mar 1, 2026 9:00 AM

FAQ

What was Chung Hwa Bio's revenue in March 2026?

Chung Hwa Bio's monthly revenue in March 2026 was 131,435,000 JPY (131.435 million JPY).

How much did the revenue increase compared to the same month last year?

It increased by 108.9% compared to the same month last year.

What kind of business does Chung Hwa Bio operate in?

Chung Hwa Bio operates in the biotechnology and medical industry.

Cite this article — HOW TO CITE

Washin AI News Desk“Chung Hwa Bio: March 2026 Revenue Reaches 131 Million (Up 108.9% Year-on-Year)”AI News by Washin Village（和心村）, Mar 1, 2026. https://aeo.idaeo.ai/ai/%E4%B8%AD%E5%8C%96%E7%94%9F/en/news/2026-04-12-chung-hwa-bio-march-2026-revenue-reaches

AI CRAWLER ACTIVITY

as of Aug 19, 2026

AI crawler visits to this article (cumulative)142 bots

Site-wide cumulative

Applebot

bot_visits_summary

2505k

last Aug 19, 2026

GPTBot

bot_visits_summary

1917k

last Aug 19, 2026

ClaudeBot

bot_visits_summary

1104k

last Aug 19, 2026

Bingbot

bot_visits_summary

662k

last Aug 19, 2026

Amazonbot

bot_visits_summary

655k

last Aug 19, 2026

Meta AI

bot_visits_summary

402k

last Aug 19, 2026

※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.

Washin AI News（AI News by Washin Village（和心村））

An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.

Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification

About the publisher IDA llms.txt

Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →

← 中化生 Back to newsroom (62)

Copied